Nvidia Corp. (NASDAQ:NVDA) has formally concluded its $5 billion purchase of Intel (NASDAQ:INTC) common stock, according to a regulatory filing released Monday.
The transaction fulfills the terms of a Securities Purchase Agreement first announced in mid-September 2025, which positioned the world’s most valuable company as a major financial backer of the struggling American chip pioneer.
The filing confirms that Nvidia purchased exactly 214,776,632 shares of Intel at a price of $23.28 per share.
The investment follows a volatile year for Intel, which has struggled with manufacturing delays and massive capital expenditures, leading to a recent 10% equity stake taken by the U.S. government to bolster domestic production.
While the $5 billion cash infusion provides a critical liquidity bridge for Intel, the deal is rooted in a deep technical collaboration designed to counter the rise of proprietary ARM-based chips.
The two companies are reportedly co-developing several product lines.
Intel will design and manufacture custom x86 CPUs featuring Nvidia’s high-speed NVLink interconnect.
These will be integrated directly into Nvidia’s AI infrastructure platforms.
The partners are also building "AI PC" system-on-chips (SoCs) that combine Intel’s x86 processors with Nvidia RTX GPU chiplets, targeting the high-end gaming and creator markets.
The closing of the deal comes just weeks after the U.S. Federal Trade Commission (FTC) cleared the transaction in early December.
Antitrust regulators reportedly scrutinized the deal for potential vertical foreclosure but ultimately ruled that the partnership was "pro-competitive," as it strengthens the x86 ecosystem against shared rivals like Apple and Qualcomm.
Despite the strategic importance of the deal, Nvidia shares traded down 1.3% in premarket activity on Monday, as investors weighed the risk of Nvidia being "too tied" to Intel’s ongoing turnaround efforts.
Meanwhile, Intel stock remained largely flat, having already staged a massive 80% recovery throughout 2025 following the appointment of new CEO Lip-Bu Tan in March.